1-2 of 2
Guihua Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Epcoritamab Plus Gemcitabine and Oxaliplatin Versus Rituximab, Gemcitabine, and Oxaliplatin in Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: A Match-Adjusted Comparative Analysis

Javier Munoz, Allison C. Rosenthal, Andrew Ip, Justin M. Darrah, Tongsheng Wang, Guihua Zhang, Alex Mutebi, Monika Jun, Zhijie Ding, Anindit Chhibber, Fernando Rivas Navarro, Malene Risum, Mohammad Atiya, Samantha Brodkin, Anthony W Wang, Abualbishr Alshreef, Diala Harb, Mariana Sacchi, Daniela Hoehn, Yasmin H. Karimi
Journal: Blood
Blood (2024) 144 (Supplement 1): 7760.
https://doi.org/10.1182/blood-2024-203876
Published: 2024
Journal Articles

Epcoritamab Plus Gemcitabine and Oxaliplatin Versus Glofitamab or Rituximab Plus Gemcitabine and Oxaliplatin in Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: A Match-Adjusted Comparative Analysis

Andrew Ip, Javier Munoz, Allison C. Rosenthal, Justin M. Darrah, Tongsheng Wang, Guihua Zhang, Alex Mutebi, Monika Jun, Zhijie Ding, Anindit Chhibber, Fernando Rivas Navarro, Malene Risum, Mohammad Atiya, Samantha Brodkin, Anthony W Wang, Abualbishr Alshreef, Diala Harb, Mariana Sacchi, Daniela Hoehn, Yasmin H. Karimi
Journal: Blood
Blood (2024) 144 (Supplement 1): 7757.
https://doi.org/10.1182/blood-2024-203540
Published: 2024